ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 118 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $997,000 | -58.9% | 523,164 | 0.0% | 0.02% | -51.4% |
| Q2 2015 | $2,425,000 | +5.9% | 523,164 | 0.0% | 0.04% | +2.9% |
| Q1 2015 | $2,289,000 | +128.0% | 523,164 | +80.5% | 0.03% | +126.7% |
| Q4 2014 | $1,004,000 | -19.5% | 289,821 | -2.5% | 0.02% | -16.7% |
| Q3 2014 | $1,247,000 | -6.0% | 297,295 | +31.3% | 0.02% | -10.0% |
| Q2 2014 | $1,327,000 | -26.5% | 226,340 | -20.9% | 0.02% | -31.0% |
| Q1 2014 | $1,805,000 | +13.2% | 286,302 | +4.9% | 0.03% | +3.6% |
| Q4 2013 | $1,595,000 | +10.1% | 272,955 | -0.7% | 0.03% | +3.7% |
| Q3 2013 | $1,449,000 | – | 274,930 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,952,891 | $2,852,000 | 0.72% |
| Nine Chapters Capital Management LLC | 180,200 | $263,000 | 0.36% |
| Camber Capital Management LP | 4,250,000 | $6,205,000 | 0.25% |
| TFS CAPITAL LLC | 340,092 | $497,000 | 0.16% |
| ASCEND CAPITAL, LLC | 1,008,949 | $1,473,000 | 0.07% |
| Acrospire Investment Management LLC | 39,781 | $58,000 | 0.05% |
| OXFORD ASSET MANAGEMENT LLP | 1,081,912 | $1,580,000 | 0.04% |
| Jacobi Capital Management LLC | 35,000 | $49,000 | 0.02% |
| Renaissance Technologies | 8,479,445 | $12,380,000 | 0.02% |
| A.R.T. Advisors, LLC | 238,036 | $347,000 | 0.02% |